1. 2630 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with locally advanced or metastatic urothelial carcinoma: A phase Ib trial. (September 2015) Authors: Apolo, A.B.; Infante, J.R.; Hamid, O.; Patel, M.; Wang, D.; Kelly, K.; Mega, A.; Britten, C.D.; Mita, A.; Ravaud, A.; Cuillerot, J.M.; Von Heydebreck, A.; Gulley, J.L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 427. Liver adenomatosis: A precancerous entity?. Issue 9 (September 2016) Authors: Frena, A.; Patauner, S.; Mega, A. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Insulin resistance improvement after effective Hepatitis C virus eradication and its role on the onset of complications of advanced liver disease. Issue 1 (February 2018) Authors: Bortoluzzi, I.; Franceschet, E.; Gambato, M.; Zanetto, A.; Ferrarese, A.; Sciarrone, S.S.; Farinati, F.; Burra, P.; Mega, A.; Russo, F.P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance. (March 2023) Authors: Reggidori, N.; Bucci, L.; Santi, V.; Stefanini, B.; Lani, L.; Rampoldi, D.; Caturelli, E.; Farinati, F.; Masotto, A.; Stefanini, B.; Mega, A.; Biasini, E.; Foschi, F.G.; Svegliati-Baroni, G.; Sangiovanni, A.; Campani, C.; Raimondo, G.; Vidili, G.; Gasbarrini, A.; Celsa, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lorentz microscopy sheds light on the role of dipolar interactions in magnetic hyperthermia. Issue 17 (2nd April 2015) Authors: Campanini, M.; Ciprian, R.; Bedogni, E.; Mega, A.; Chiesi, V.; Casoli, F.; de Julián Fernández, C.; Rotunno, E.; Rossi, F.; Secchi, A.; Bigi, F.; Salviati, G.; Magén, C.; Grillo, V.; Albertini, F. Journal: Nanoscale Issue: Volume 7:Issue 17(2015) Page Start: 7717 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.01.3 METABOLIC CHANGES AFTER DAA TREATMENT IN HCV PATIENTS: A MULTICENTRIC STUDY. (25th March 2019) Authors: Mega, A.; Zoller, H.; Piccin, A.; De Marchi, F.; Kob, M.; Marzi, L.; Mueller, T.; Daves, M.; Falciani, M.; Primerano, M.; Haefner, M.; Russo, F.P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.04.4 SUPERVISED MACHINE LEARNING TECHNIQUES FOR THE PREDICTION OF HEPATOCELLULAR CARCINOMA (HCC) RELAPSE. (September 2021) Authors: Mega, A.; Andreotti, A.; Vittadello, F.; Marzi, L.; Ferro, F.; Erdini, F.; Pedrazzoli, A.; Gitto, S.; De Marchi, F.; Comberlato, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB. (March 2023) Authors: Sacco, R.; Ciruolo, M.; Paolillo, R.; Ramai, D.; Tortora, R.; Di, Costanzo G.G.; Burlone, M.; Pirisi, M.; Federico, P.; Daniele, B.; Silletta, M.; Gallo, P.; Cocuzza, C.; Russello, M.; Cabibbo, G.; Cesario, S.; Masi, G.; Marzi, L.; Mega, A.; Granito, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.13.5: Validation of the Bolondi Stratification for Intermediate Stage HCC. Clinical and Therapeutical Implications. (15th March 2017) Authors: Mega, A.; Degiorgio, M.; Zoller, H.; Finkenstedt, A.; Felder, M.; Pedrazzoli, A.; Piccin, A.; Dipierro, A.; Haefner, M. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome. (March 2021) Authors: Guarino, M.; Cucchetti, A.; Pontillo, G.; Farinati, F.; Benevento, F.; Rapaccini, G.L.; Marco, M. Di; Caturelli, E.; Zolii, M.; Sacco, R.; Cabibbo, G.; Marra, F.; Mega, A.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F.G.; Missale, G.; Masotto, A.; Nardone, G.; Raimondo, G. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗